In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer is a research paper published in Pharmaceutics (2024). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Kuwait Foundation for the Advancement of Sciences (KFAS)
Grant: CB21-63SP-01
Kuwait Foundation for the Advancement of Sciences (KFAS)
Grant: R01CA257241
Kuwait Foundation for the Advancement of Sciences (KFAS)
Grant: R01DE028105
Kuwait Foundation for the Advancement of Sciences (KFAS)
Grant: R21CA252156
Kuwait Foundation for the Advancement of Sciences (KFAS)
Grant: R01CA274415
National Institutes of Health
Grant: 5R01DE028105-03
Enhancing immune mediated head and neck cancer anti-tumor activity using nanoparticles
Natural Sciences and Engineering Research Council of Canada
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01CA257241-05
Rational translation of gold nanoparticle mediated radiosensitization to the clinic
National Institutes of Health
Grant: 1R21CA252156-01
In situ cancer cell specific synthesis of gold nanoclusters for radiosensitization of pancreatic cancer
National Institutes of Health
Grant: 5R01CA274415-03
In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy
Nanomedicines Innovation Network Strategic Initiative
Grant: 2021-RES-SI-05
Natural Sciences and Engineering Research Council
Grant: RGPIN-2017-04501
Fields of Study
Keywords
Sustainable Development Goals
In Vitro and In Vivo Synergetic Radiotherapy with Gold Nanoparticles and Docetaxel for Pancreatic Cancer